Logo image of RKLY

ROCKLEY PHOTONICS HOLDINGS L (RKLY) Stock Fundamental Analysis

NYSE:RKLY - New York Stock Exchange, Inc. - KYG7614L1095 - Common Stock - Currency: USD

0.1924  +0.01 (+3.55%)

After market: 0.1851 -0.01 (-3.79%)

Fundamental Rating

2

Taking everything into account, RKLY scores 2 out of 10 in our fundamental rating. RKLY was compared to 110 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and financial health of RKLY have multiple concerns. While showing a medium growth rate, RKLY is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

RKLY had negative earnings in the past year.
RKLY had a negative operating cash flow in the past year.
RKLY Yearly Net Income VS EBIT VS OCF VS FCFRKLY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 -50M -100M -150M

1.2 Ratios

RKLY has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RKLY Yearly ROA, ROE, ROICRKLY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 0 100 -100 200

1.3 Margins

RKLY does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RKLY Yearly Profit, Operating, Gross MarginsRKLY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 -500 -1K -1.5K -2K

More info and screens

3

2. Health

2.1 Basic Checks

RKLY does not have a ROIC to compare to the WACC, probably because it is not profitable.
RKLY has more shares outstanding than it did 1 year ago.
RKLY has a better debt/assets ratio than last year.
RKLY Yearly Shares OutstandingRKLY Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 20M 40M 60M 80M 100M
RKLY Yearly Total Debt VS Total AssetsRKLY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 50M 100M 150M

2.2 Solvency

RKLY has an Altman-Z score of -13.29. This is a bad value and indicates that RKLY is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -13.29, RKLY is not doing good in the industry: 83.81% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -13.29
ROIC/WACCN/A
WACC5.9%
RKLY Yearly LT Debt VS Equity VS FCFRKLY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 0 50M -50M 100M -100M

2.3 Liquidity

RKLY has a Current Ratio of 2.13. This indicates that RKLY is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.13, RKLY is doing worse than 76.19% of the companies in the same industry.
A Quick Ratio of 2.13 indicates that RKLY has no problem at all paying its short term obligations.
RKLY has a Quick ratio (2.13) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 2.13
RKLY Yearly Current Assets VS Current LiabilitesRKLY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

RKLY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.15%, which is quite good.
Looking at the last year, RKLY shows a very negative growth in Revenue. The Revenue has decreased by -40.23% in the last year.
EPS 1Y (TTM)17.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%125.93%
Revenue 1Y (TTM)-40.23%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-69.77%

3.2 Future

Based on estimates for the next years, RKLY will show a very strong growth in Earnings Per Share. The EPS will grow by 20.33% on average per year.
Based on estimates for the next years, RKLY will show a very strong growth in Revenue. The Revenue will grow by 109.59% on average per year.
EPS Next Y15.64%
EPS Next 2Y26.89%
EPS Next 3Y20.33%
EPS Next 5YN/A
Revenue Next Year-52.4%
Revenue Next 2Y74.54%
Revenue Next 3Y109.59%
Revenue Next 5YN/A

3.3 Evolution

RKLY Yearly Revenue VS EstimatesRKLY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 20M 40M 60M
RKLY Yearly EPS VS EstimatesRKLY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 -0.5 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

RKLY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RKLY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RKLY Price Earnings VS Forward Price EarningsRKLY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RKLY Per share dataRKLY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

RKLY's earnings are expected to grow with 20.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.89%
EPS Next 3Y20.33%

More info and screens

0

5. Dividend

5.1 Amount

RKLY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ROCKLEY PHOTONICS HOLDINGS L

NYSE:RKLY (1/23/2023, 8:04:01 PM)

After market: 0.1851 -0.01 (-3.79%)

0.1924

+0.01 (+3.55%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-09 2022-11-09/amc
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners13.91%
Ins Owner Change0%
Market Cap25.52M
Analysts80
Price Target1.53 (695.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-35.52%
Min EPS beat(2)-224.82%
Max EPS beat(2)153.78%
EPS beat(4)2
Avg EPS beat(4)-3.58%
Min EPS beat(4)-224.82%
Max EPS beat(4)153.78%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-65.17%
Min Revenue beat(2)-66.66%
Max Revenue beat(2)-63.68%
Revenue beat(4)1
Avg Revenue beat(4)-39.87%
Min Revenue beat(4)-69.38%
Max Revenue beat(4)40.24%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-73.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)17.38%
EPS NY rev (1m)0%
EPS NY rev (3m)26.59%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-90.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-60.6%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.7
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.08
EYN/A
EPS(NY)-0.55
Fwd EYN/A
FCF(TTM)-1.18
FCFYN/A
OCF(TTM)-1.14
OCFYN/A
SpS0.04
BVpS-0.23
TBVpS-0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 84.73%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.13
Quick Ratio 2.13
Altman-Z -13.29
F-Score3
WACC5.9%
ROIC/WACCN/A
Cap/Depr(3y)130.71%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%125.93%
EPS Next Y15.64%
EPS Next 2Y26.89%
EPS Next 3Y20.33%
EPS Next 5YN/A
Revenue 1Y (TTM)-40.23%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-69.77%
Revenue Next Year-52.4%
Revenue Next 2Y74.54%
Revenue Next 3Y109.59%
Revenue Next 5YN/A
EBIT growth 1Y-31.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-4.92%
EBIT Next 3Y10.35%
EBIT Next 5YN/A
FCF growth 1Y-168.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-160.58%
OCF growth 3YN/A
OCF growth 5YN/A